These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32300784)
21. Drug resistance in children and adolescents with HIV in Panama. Ventosa-Cubillo J; Pinzón R; González-Alba JM; Estripeaut D; Navarro ML; Holguín Á J Antimicrob Chemother; 2023 Feb; 78(2):423-435. PubMed ID: 36454248 [TBL] [Abstract][Full Text] [Related]
22. Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China. Pang X; He Q; Tang K; Huang J; Fang N; Xie H; Ma J; Zhu Q; Lan G; Liang S J Antimicrob Chemother; 2024 May; 79(5):1142-1152. PubMed ID: 38551451 [TBL] [Abstract][Full Text] [Related]
23. Men with a history of commercial heterosexual contact play essential roles in the transmission of HIV-1 CRF55_01B from men who have sex with men to the general population in Guangxi, China. Luo T; Zhang F; Liang H; Yu D; Cen P; Zhong S; Qin C; Yang Y; Jiang J; Liao Y; Li M; Zhang R; Li Z; Lin Z; Ye L; Liang H; Liang B Front Cell Infect Microbiol; 2024; 14():1391215. PubMed ID: 39247056 [TBL] [Abstract][Full Text] [Related]
24. Changes from 2000 to 2009 in the Prevalence of HIV-1 Containing Drug Resistance-Associated Mutations from Antiretroviral Therapy-Naive, HIV-1-Infected Patients in the United States. Ross LL; Shortino D; Shaefer MS AIDS Res Hum Retroviruses; 2018 Aug; 34(8):672-679. PubMed ID: 29732898 [TBL] [Abstract][Full Text] [Related]
25. Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. Boender TS; Kityo CM; Boerma RS; Hamers RL; Ondoa P; Wellington M; Siwale M; Nankya I; Kaudha E; Akanmu AS; Botes ME; Steegen K; Calis JC; Rinke de Wit TF; Sigaloff KC J Antimicrob Chemother; 2016 Oct; 71(10):2918-27. PubMed ID: 27342546 [TBL] [Abstract][Full Text] [Related]
26. HIV-1 Drug Resistance, Distribution of Subtypes, and Drug Resistance-Associated Mutations in Virologic Failure Individuals in Chengdu, Southwest China, 2014-2016. Chen J; Liu Y; Liu S; Yuan D; Su L; Ye L; Gong F; Gao Y; Baloch S; Pei X Biomed Res Int; 2020; 2020():5894124. PubMed ID: 32280691 [TBL] [Abstract][Full Text] [Related]
27. Impact of HIV-1 CRF55_01B infection on the evolution of CD4 count and plasma HIV RNA load in men who have sex with men prior to antiretroviral therapy. Wei L; Li H; Lv X; Zheng C; Li G; Yang Z; Chen L; Han X; Zou H; Gao Y; Cheng J; Wang H; Zhao J Retrovirology; 2021 Aug; 18(1):22. PubMed ID: 34399785 [TBL] [Abstract][Full Text] [Related]
28. Tracing the transmission dynamics of HIV-1 CRF55_01B. Zai J; Liu H; Lu Z; Chaillon A; Smith D; Li Y; Li X Sci Rep; 2020 Mar; 10(1):5098. PubMed ID: 32198405 [TBL] [Abstract][Full Text] [Related]
29. Characterization of HIV drug resistance mutations among patients failing first-line antiretroviral therapy from a tertiary referral center in Lusaka, Zambia. Seu L; Mulenga LB; Siwingwa M; Sikazwe I; Lambwe N; Guffey MB; Chi BH J Med Virol; 2015 Jul; 87(7):1149-57. PubMed ID: 25754408 [TBL] [Abstract][Full Text] [Related]
30. HIV-1 Drug Resistance Mutations among Antiretroviral Drug-Experienced Patients in the South of Iran. Memarnejadian A; Nikpoor AR; Davoodian N; Kargar A; Mirzadeh Y; Gouklani H Intervirology; 2019; 62(2):72-79. PubMed ID: 31311021 [TBL] [Abstract][Full Text] [Related]
31. [Analysis of HIV-1 genetic subtype and pretreatment drug resistance among men who have sex with men infected with HIV-1 from 19 cities of 6 provinces in China]. Zhang R; Dong TL; Liang WL; Cao ZB; Xie Z; Liu KM; Yu F; Fu GF; Zhang YQ; Wang GY; Ma QQ; Wu SB; Li Y; Dong W; Jiang Z; Xu J; Wu ZY; Yao J; Pan PL; Qiu MF Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):523-527. PubMed ID: 35443307 [No Abstract] [Full Text] [Related]
32. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa. Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647 [TBL] [Abstract][Full Text] [Related]
33. Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China. Lv S; Lan Y; He Y; Li Q; Ling X; Li J; Li L; Guo P; Hu F; Cai W; Tang X; Chen J; Li L J Med Virol; 2024 Oct; 96(10):e29937. PubMed ID: 39323078 [TBL] [Abstract][Full Text] [Related]
34. [Prevalence of drug resistance in treatment-naive HIV infected men who have sex with men in Guangzhou, 2008-2015]. Han ZG; Zhang YL; Wu H; Gao K; Zhao YT; Gu YZ; Chen YC Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jul; 39(7):977-982. PubMed ID: 30060315 [No Abstract] [Full Text] [Related]
35. Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine. Gallien S; Charreau I; Nere ML; Mahjoub N; Simon F; de Castro N; Aboulker JP; Molina JM; Delaugerre C J Antimicrob Chemother; 2015 Feb; 70(2):562-5. PubMed ID: 25344807 [TBL] [Abstract][Full Text] [Related]
36. The prevalence of CRF55_01B among HIV-1 strain and its connection with traffic development in China. Gan M; Zheng S; Hao J; Ruan Y; Liao L; Shao Y; Feng Y; Xing H Emerg Microbes Infect; 2021 Dec; 10(1):256-265. PubMed ID: 33512306 [TBL] [Abstract][Full Text] [Related]
37. Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine. Theys K; Camacho RJ; Gomes P; Vandamme AM; Rhee SY; Clin Microbiol Infect; 2015 Jun; 21(6):607.e1-8. PubMed ID: 25704446 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of HIV-1 drug resistance among patients failing first-line antiretroviral therapy in Ethiopia. Getaneh Y; He Q; Rashid A; Kassa D; Kang L; Yi F; Liao L; Shao Y J Glob Antimicrob Resist; 2022 Sep; 30():418-427. PubMed ID: 35917929 [TBL] [Abstract][Full Text] [Related]
39. In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations. Saladini F; Giammarino F; Hosseini BA; Giannini A; Boccuto A; Dragoni F; Vicenti I; Shafer RW; Zazzi M J Antimicrob Chemother; 2021 Jan; 76(1):130-134. PubMed ID: 32974670 [TBL] [Abstract][Full Text] [Related]
40. High prevalence of virological failure and HIV drug mutations in a first-line cohort of Malawian children. Huibers MHW; Moons P; Cornelissen M; Zorgdrager F; Maseko N; Gushu MB; Iwajomo OH; Boele van Hensbroek M; Calis JCJ J Antimicrob Chemother; 2018 Dec; 73(12):3471-3475. PubMed ID: 30169653 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]